Musculoskeletal Diseases Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Musculoskeletal Diseases Market
Musculoskeletal Diseases Market: By Type (Rheumatoid arthritis, Osteoarthritis, Osteoporosis, others), By Treatment (biologics, corticosteroids, parathyroid hormone, Others) & By Region-Forecast (2016-2021)
Report Code : HCR 0323
Published: 22 January, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Musculoskeletal diseases/disorders (MSDs) are diseases of muscles and related ligaments, and other connective tissues and bones. Some of the most common musculoskeletal diseases are back pain, osteoarthritis, rheumatoid arthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, systemic lupus erythematosus (SLE), and some others. Globally, development of efficient and advance technology, rise in the awareness among people, increasing government initiative across the globe, growing healthcare expenditure, and growing development and commercialization of pipeline drugs are the prime growth drivers of global Musculoskeletal Diseases market. In addition, increase in adoption of Musculoskeletal Diseases drugs in emerging economies such as China, India and others, will create new opportunities for global Musculoskeletal Diseases market. However, higher cost of the research and development, complex government approval process and risk of side effects are the key restraints for global Musculoskeletal Diseases market.

 Musculoskeletal Diseases Market

Geographically Americas dominated global Musculoskeletal Diseases market, because of over-use of weak muscles, tendons, or ligaments, vigorous vocational activities. Asia Pacific is projected to have fastest growth, owing to prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and degenerative disc diseases increase in developing nations such as China, and India in this region. Among all the treatments, biologics procedures has the highest market share in global Musculoskeletal Diseases market due to higher prevalence of cancer patients.

This report identifies the global Musculoskeletal Diseases market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Musculoskeletal Diseases market.

This report segments global Musculoskeletal Diseases market based on type, treatment, and regional market as follows:
  • Musculoskeletal Diseases Market, By Type: Rheumatoid arthritis, Osteoarthritis, Osteoporosis, and Others
  • The report has focused study on Musculoskeletal Diseases market by basis of end-user such as: Biologics, Corticosteroids, Parathyroid Hormone,  and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Musculoskeletal Diseases market. Some of the major companies’ profiles in detail are as follows:
  • AB Sciences.
  • AbGenomics International.
  • Alder BioPharmaceuticals
  • Amgen Astellas BioPharma.
  • Antares Medical Services
1. Musculoskeletal Diseases Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Musculoskeletal Diseases Market– Market Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. development and commercialization of pipeline drugs
   4.2. Restraints
      4.2.1. Higher cost of research and development
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Musculoskeletal Diseases Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Musculoskeletal Diseases Market, By Type
   6.1. Rheumatoid arthritis
   6.2. Osteoarthritis
   6.3. Osteoporosis
   6.4. Psoriatic arthritis
   6.5. Ankylosing spondylitis
   6.6. Fibromyalgia
7. Musculoskeletal Diseases Market, By Treatment
   7.1. Biologics
   7.2. Corticosteroids
   7.3. Parathyroid hormone
   7.4. Protein therapy
   7.5. Selective estrogen receptor modulators
   7.6. Synthetic bone graft
   7.7. Composite grafts
   7.8. Demineralized bone matrix
   7.9. BMPS
8. Musculoskeletal Diseases Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Musculoskeletal Diseases – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. AB Sciences.
   10.2. AbGenomics International.
   10.3. Alder BioPharmaceuticals
   10.4. Amgen Astellas BioPharma.
   10.5. Antares Medical Services
   10.6. Lexicon Pharmaceuticals
   10.7. LG Life Sciences.
   10.8. OrthoTrophix
   10.9. Tarsa Therapeutics
   10.10. PhytoHealth Corporation.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll